Using UNC's expertise to fight emerging diseases

Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (

Share: Facebook | Twitter | Email


Recent Campus Connections News:

Incoming UNC graduate student runs across the country 4,000 miles for a cause

Best burger in U.S. is at Al's Burger Shack in Chapel Hill

Video: UNC doctors work to contain African Ebola outbreak

Carolina Performing Arts receives $1.5 million grant from The Andrew W. Mellon Foundation

From Chapel Hill to Bowie and Emmitsburg, A Life in the Booth

© 2005-2018 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.